Tatyana M. Nalimova

ORCID: 0000-0001-8408-0930
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Plant Virus Research Studies
  • Bacteriophages and microbial interactions

State Research Center of Virology and Biotechnology VECTOR
2021-2023

Infectious Clinical Hospital No. 1
2023

Novosibirsk State Medical University
2023

Kyrgyzstan has one of the highest rates HIV-1 spread in Central Asia. In this study, we used molecular-epidemiological approaches to examine epidemic Kyrgyzstan. Samples were obtained from HIV-positive individuals who visited HIV/AIDS clinics. Partial pol gene sequences identify subtypes and drug resistance mutations (DRMs) perform phylogenetic analysis. Genetic diversity history reconstruction major explored using BEAST. This study includes an analysis 555 individuals. The population was...

10.3389/fmicb.2021.753675 article EN cc-by Frontiers in Microbiology 2021-10-15

HIV-1 epidemic in Russia is one of the fastest growing world reaching 1.14 million people living with (PLWH) 2021. Since mid-1990s, has started to grow substantially due multiple outbreaks among persons who inject drugs (PWID) leading expansion sub-subtype A6 (former Soviet Union (FSU) subtype A). In 2006, a local sub-epidemic caused by distribution novel genetic lineage CRF63_02A6 was identified Siberia. this study, we used comprehensive dataset pol gene sequences investigate spatiotemporal...

10.3389/fmicb.2022.946787 article EN cc-by Frontiers in Microbiology 2022-08-31

Introduction. Over the past 10 years, there has been an increase in HIV-1 resistance to antiretroviral drugs worldwide. HIV infection patients with low adherence therapy (ART) are most often at risk of developing acquired resistance. The identification key factors affecting degree will allow timely detection a high poor ART and treatment defaulting, develop individual management tactics for such reduce development. Aim. To study influencing virological failure effect on first-line drugs....

10.31549/2542-1174-2024-8-1-29-41 article EN JOURNAL of SIBERIAN MEDICAL SCIENCES 2024-01-01

РУБРИКА ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ Резистентность ВИЧ-1 к препаратам первой линии антиретровирусной терапии1 Федеральное государственное бюджетное образовательное учреждение высшего образования «Новосибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации

10.33029/2305-3496-2023-12-3-79-87 article RU Infectious diseases News Opinions Training 2023-01-01
Coming Soon ...